Drugs of abuse bypass the normal mechanisms that regulate release of dopamine, producing longterm changes in the neural systems that govern reward. Association with dopamine release enables environmental cues to activate the reward pathway, thus promoting either adaptive behavior or drug addiction. However, we still understand little about the physiological mechanisms that regulate dopamine release, the changes in release that underlie both normal, adaptive behavior and addiction, or the mechanisms by which dopamine controls the reward pathway. Dopamine differs from other classical transmitters in several respects. First, dopamine activates G protein-coupled receptors through volume transmission, making it difficult to understand how dopamine can convey a signal with the temporal resolution required to associate transient environmental cues with reward. Interestingly, recent work has shown that dopamine neurons also release glutamate, but the physiological role of glutamate co-release remains unclear. Second, dopamine undergoes release from dendrites as well as presynaptic boutons, and dendritic dopamine release has been considered to play a particularly important role in plasticity of the reward system. Dendritically released dopamine activates autoreceptors on dopamine neurons, and through Dl receptors, appears to influence synaptic inputs onto midbrain dopamine neurons and to control outflow from the basal ganglia through the substantia nigra pars reticulata (SNr). However, the mechanisms responsible for dendritic dopamine release and the physiological role of Dl receptor activation in the midbrain remain unclear. This program will thus address multiple presynaptic mechanisms highly relevant to the release and action of dopamine in the reward pathway: 1) The mechanism of dendritic dopamine release (Projects 1 and 3);2) The mechanism and physiological role of glutamate co-release by dopamine neurons (Project 3);3) Trafficking and regulation

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
2P01DA010154-16A1
Application #
8339181
Study Section
Special Emphasis Panel (ZRG1-MDCN-F (50))
Program Officer
Sorensen, Roger
Project Start
1997-09-05
Project End
2017-04-30
Budget Start
2012-07-15
Budget End
2013-04-30
Support Year
16
Fiscal Year
2012
Total Cost
$1,128,057
Indirect Cost
$240,187
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Eichel, Kelsie; JulliƩ, Damien; Barsi-Rhyne, Benjamin et al. (2018) Catalytic activation of ?-arrestin by GPCRs. Nature 557:381-386
Dunn, Matthew; Henke, Adam; Clark, Samuel et al. (2018) Designing a norepinephrine optical tracer for imaging individual noradrenergic synapses and their activity in vivo. Nat Commun 9:2838
Fischer, Kathryn D; Houston, Alex C W; Desai, Rajeev I et al. (2018) Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine. Psychopharmacology (Berl) 235:1371-1387
Eichel, Kelsie; von Zastrow, Mark (2018) Subcellular Organization of GPCR Signaling. Trends Pharmacol Sci 39:200-208
Bamford, Nigel S; Wightman, R Mark; Sulzer, David (2018) Dopamine's Effects on Corticostriatal Synapses during Reward-Based Behaviors. Neuron 97:494-510
Ullman, Julie C; Yang, Jing; Sullivan, Michael et al. (2018) A mouse model of autism implicates endosome pH in the regulation of presynaptic calcium entry. Nat Commun 9:330
Henke, Adam; Kovalyova, Yekaterina; Dunn, Matthew et al. (2018) Toward Serotonin Fluorescent False Neurotransmitters: Development of Fluorescent Dual Serotonin and Vesicular Monoamine Transporter Substrates for Visualizing Serotonin Neurons. ACS Chem Neurosci 9:925-934
Dunn, Matthew; Boltaev, Umed; Beskow, Anne et al. (2018) Identification of Fluorescent Small Molecule Compounds for Synaptic Labeling by Image-Based, High-Content Screening. ACS Chem Neurosci 9:673-683
Borgkvist, Anders; Lieberman, Ori J; Sulzer, David (2018) Synaptic plasticity may underlie l-DOPA induced dyskinesia. Curr Opin Neurobiol 48:71-78
Liang, Samantha I; van Lengerich, Bettina; Eichel, Kelsie et al. (2018) Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras. Cell Rep 22:2593-2600

Showing the most recent 10 out of 128 publications